Key takeaways:
Survivorship free of all-cause revision was 96% at 15 years in the hip resurfacing cohort.
Survivorship free of aseptic revision was 97.4% at 15 years in the hip resurfacing cohort.
Published results showed a hip resurfacing implant may be an effective treatment option for younger, active men with osteoarthritis.
“We studied [the implant] all along the way and to the end of the road — 15 years — and the revision rates were as low as any hip procedure we do,” Robert L. Barrack , MD, Charles and Joanne Knight Distinguished Professor in the department of orthopedic surgery at Washington University School of Medicine in St. Louis, Missouri, told Healio.
Data were derived from Zuke WA, et al. J Bone Joint Surg Am . 2025;doi:10.2106/JBJS.24.00926.
Barrack and colle